Some of these medications, such as antiglaucoma and dilating agents, have important ... well studied in pediatric patients. [1] There is a particular paucity of information on drug use in patients ...

“The FDA’s Rare Pediatric Disease and Orphan Drug designations for ST-01156 represent an important milestone, recognizing its potential to address significant unmet needs in rare oncology ...

INDIANAPOLIS — It’s a club no parent wants to belong to, losing a child. Wednesday, several parents who know what that pain ...

The new drug application is supported by 3-year data from the STAR study. If approved, SYD-101 would be the first pharmaceutical treatment to slow the progression of pediatric myopia in the U.S ...

To achieve efficacy, pediatric anesthesiologists use age-appropriate protocols and pain management strategies. These ...